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Cellular morphological changes 
detected by laser scanning in vivo 
confocal microscopy associated 
with clinical outcome in fungal 
keratitis
Jaya D. Chidambaram  1, Namperumalsamy V. prajna2,3, srikanthi palepu2, shruti Lanjewar2, 
Manisha shah2,3, shanmugam elakkiya3, prajna Lalitha2,3, David Macleod1 & 
Matthew J. Burton1,4
HRT3 in vivo confocal microscopy (IVCM) images may indicate clinical outcome, but few studies have 
analysed this in fungal keratitis (FK). Adults with FK (diameter ≥3 mm) presenting to Aravind Eye 
Hospital, India from 2012-3 were enrolled prospectively. IVCM was performed at baseline, days 7, 14 
and 21 post-enrolment (+/− 3 days where possible). Specific morphologies were identified in IVCM 
images by a grader masked to microbiology and clinical outcome (defined as good: healed/improving, 
or poor: enlarged ulcer, perforation or transplant/glue). Associations with final visit outcome assessed 
using logistic regression. 143 FK participants were enrolled; 87 had good outcome, 56 had poor 
outcome. poor outcomes were associated with stellate interconnected cellular processes with no visible 
nuclei (OR 2.28, 95% CI: 1.03–5.06, p = 0.043) in baseline IVCM images, and fungal filaments (OR 6.48, 
95% CI:2.50–16.78, p < 0.001) or honeycomb distribution of inflammatory cells (OR 5.24, 95% CI: 1.44–
19.06, p = 0.012) in final visit images. Fungal filaments (OR 3.61, 95% CI:1.64–7.95, p = 0.001), stromal 
dendritiform cells (OR 2.88, 95% CI:1.17–7.11, p = 0.022), or stellate cellular processes with no visible 
nuclei (OR 2.09, 95% CI:1.14–3.82, p = 0.017) were associated with poor outcome if not in baseline but 
present in final visit images. IVCM can reveal morphological changes associated with clinical outcome.
After initiation of antimicrobial therapy for microbial keratitis (MK), it may be difficult to assess therapeutic 
response of some ulcers based upon clinical appearances alone1. In vivo confocal microscopy (IVCM) is a useful 
aid in detecting pathogens >1μm in size in the living cornea, i.e. fungal hyphae and Acanthamoeba cysts but not 
most bacteria2. Specific cellular morphologies observed with IVCM, such as increase in the number of activated 
keratocytes have been previously postulated as early predictors of disease, e.g. graft rejection after penetrating 
keratoplasty3. Only a few studies have used IVCM to assess changes during the clinical course of MK1. Winchester 
et al. used tandem-scanning IVCM in two patients with fungal keratitis (FK) and showed that Aspergillus hyphae 
broke into shorter fragments by day 4 post-natamycin therapy, and disappeared completely by day 124. Shi et al. 
used the confoscan IVCM to monitor 121 FK patients during antifungal therapy, and observed that fungal hyphae 
disappeared over time in parallel with reduction in the inflammatory cell infiltrate, however no quantitative data 
were presented on the association of specific IVCM cellular changes with clinical outcome5. Heidelberg retinal 
tomography 3 IVCM with the Rostock Corneal Module (HRT3 IVCM) has a higher resolution than either the 
tandem-scanning or confoscan IVCM and therefore allows an improved view of cells within corneal tissue6. 
Cellular processes and nuclei of activated keratocytes can be observed in greater detail using the HRT3 IVCM6, 
as well as other morphological appearances such as presence of round inflammatory cells and dendritiform cells.
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To our knowledge, use of serial HRT3 IVCM to assess the cellular changes in MK has not been previously 
reported. Therefore, in this study we quantitatively assessed serial HRT3 IVCM images from a prospective cohort 
of severe bacterial and fungal keratitis patients in South India for morphological features that were associated 
with healing or worsening clinical outcome. We chose to focus on moderate-to-severe keratitis in this study since 
these ulcers often present with an atypical clinical appearance and may be difficult to manage during their clinical 
course7, therefore we felt these ulcers would benefit the most from investigation of the cellular response with the 
use of IVCM.
Methods
This study was prospectively approved by the Ethics Committees of the Indian Council for Medical Research, 
Aravind Eye Hospital, Tamil Nadu, India, and the London School of Hygiene & Tropical Medicine, UK. All 
experiments were carried out in accordance with the relevant guidelines and regulations. All patients gave written 
informed consent prior to enrolment; illiterate participants gave informed consent with a witnessed thumbprint 
on the study consent form.
From February 2012 to February 2013, consecutive patients presenting to the Cornea Clinic of Aravind Eye 
Hospital, Madurai, Tamil Nadu, India were assessed for eligibility with the following inclusion criteria: age ≥18 
years, stromal infiltrate diameter ≥3 mm, presence of overlying epithelial defect and signs of acute inflammation. 
Patients were excluded if the ulcer had a descemetocoele or >80% corneal thinning as assessed by slit lamp 
examination (since applanation for IVCM could not safely be done in these patients); clinical features or prior 
history of herpetic keratitis; Snellen visual acuity worse than 6/60 in the unaffected eye; Acanthamoeba keratitis 
diagnosed on culture and/or IVCM (these patients were followed up in a different study); or presence of mixed 
infection (i.e. culture-positive for bacteria and light microscopy and/or IVCM positive for fungus). At enrolment, 
data from a focused clinical history and slit lamp examination were recorded. The study follow-up visit schedule 
was as follows: days 7 (+/− 3 days), 14 (+/− 3 days) and 21 (+/− 3 days). Final visit assessment with IVCM 
imaging was included for patients unable to attend at 21 (+/− 3 days), but who attended later up to a maximum 
of 37 days post-enrolment. Additional assessments were scheduled as clinically indicated. At each visit, the cornea 
consultant or cornea fellow examined every study participant and management followed the standard of care for 
microbial keratitis at Aravind Eye Hospital (AEH). The standard of care for the treatment of fungal keratitis at 
AEH is as per the World Health Organization’s guidelines for the management of microbial keratitis8, i.e. intensive 
topical natamycin 5% eyedrop therapy every 1 hour day and night (with hospital admission for severe ulcers), and 
drop frequency slowly tapered as per clinical response. In addition to topical therapy, oral antifungal medication 
(e.g. ketoconazole, itraconazole or voriconazole) was added in cases of large, deep ulcers or ulcers close to the 
limbus. Adjunctive therapy with topical cycloplegic agents or anti-glaucoma medications were given as required. 
Where there was clinical suspicion of bacterial infection, empirical therapy with intensive topical antibiotic (e.g. 
fluoroquinolone such as moxifloxacin or levofloxacin, or fortified cefazolin or fortified gentamicin) was used in 
addition to the antifungal therapy, as per the recommendation of the corneal specialist. The antibiotic was then 
tapered and/or stopped as per clinical response and along with availability of microbiological results from cor-
neal scrape testing. Any participant with significant worsening of the ulcer despite maximal medical therapy (e.g. 
perforation or impending perforation, significant enlargement of the infiltrate) underwent surgical intervention 
(i.e. therapeutic penetrating keratoplasty; corneal glue for small perforations; intrastromal voriconazole for deep 
stromal abscess in fungal keratitis).
Clinical outcomes were assessed based on slit lamp examination of the cornea including measurements of the 
ulcer at each visit with grading as follows: (1) healed: no epithelial defect at final visit with presence of scar tissue; 
(2) improving: final visit infiltrate size less than enrolment size with or without epithelial defect still present; (3) 
worsening: final visit infiltrate size either the same as or larger than enrolment infiltrate size, if corneal perforation 
was noted (i.e. full-thickness hole seen in cornea at slit lamp, or iris plugging site of possible corneal perforation 
with flat anterior chamber and seidel-positivity), or if surgical intervention was performed. The “final visit” was 
defined as either the clinical assessment/IVCM imaging performed at the end of the study (i.e. up to 37 days 
post-enrolment) or the visit when the patient left the study due to surgical intervention. Ulcers were categorized 
as having a “Good” outcome if they healed or were improving, and categorized as having a “Poor” outcome if they 
had worsened or perforated by the final visit.
IVCM Imaging. HRT3 IVCM imaging (Heidelberg Engineering, Germany) of the corneal ulcer was per-
formed immediately prior to corneal scraping for microbiological tests, as described in detail elsewhere2,9. 
Proparacaine 0.5% eyedrop anaesthesia was used (Aurocaine, Aurolab, Madurai, India) and the RCM (Heidelberg 
Engineering, Germany) with 63x objective lens (Nikon, Japan) was gently applanated to the corneal surface. 
Using the HRT3 IVCM (Heidelberg Engineering, Germany), volume scans were obtained in a systematic manner 
at the center of the ulcer and ulcer margins (12, 3, 6 and 9 o’clock positions). By manually refocusing the Rostock 
Corneal Module we obtained a series of volume scans covering consecutive 80 micron depths from epithelium 
to endothelium, where possible, in each of these cardinal locations at the ulcer margins and center. This imag-
ing method has been previously used to systematically scan the cornea in prior publications2,10. IVCM imaging 
was repeated using the same methodology at each follow-up visit. After IVCM imaging, corneal scrapes were 
obtained from the leading margin and base of the ulcer for culture and light microscopy, using standard proce-
dures described in detail elsewhere2.
IVCM Grading. IVCM volume-scan images were assigned a random identification number, had 
patient-identifying data removed, and were shuffled into a random order. A single experienced grader per-
formed all image grading and was masked to the clinical features and microbiological diagnosis. Images 
from each visit were graded independently from all other visits. All data were recorded in a Microsoft Access 
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database. The grading scheme included presence/absence of the following morphological features in any single 
IVCM image as described in Table 1: fungal filaments (Fig. 1A), corneal epithelial or stromal bullae (Fig. 1B), 
homogenous-acellular scar-like tissue (Fig. 1C), linear “spindles” (Fig. 1D), or dendritiform cells in either the 
basal epithelial layer or stroma (Fig. 1E). Presence/absence of the following morphological features were also 
assessed: normal, quiescent keratocytes (i.e. bright ovoid nuclei with barely visible cellular processes; Fig. 2A); 
stellate structures with bright interconnected broad cellular processes either with or without visible bright ovoid 
nuclei (“activated” keratocytes, as shown in Fig. 2B,C respectively); inflammatory cells in either a honeycomb 
distribution (Fig. 2D) or a non-specific distribution; or “granules” (i.e. 1–2μm diameter bright opacities within 
the nucleus or cellular processes; Fig. 2C).
statistical methods. All statistical analyses were performed in Stata 13.1 (StataCorp, Texas, USA). Logistic 
regression analysis was used to assess statistical significance of differences in morphological features in ulcers 
with poor outcome versus good outcome in the baseline visit IVCM images and then in the final visit images. 
Conditional logistic regression analysis was used to assess change in morphological features within each patient’s 
images from baseline to the final visit, with poor versus good outcome as the dependent variable (i.e. although 
patients may have been followed up at different times for their final visit, this factor is taken into account as the 
conditional logistic regression analysis only analyses the change within each patient alone, not a comparison 
between patient groups). All regression analyses were adjusted for age, gender, baseline ulcer stromal infiltrate 
size (defined as the geometric mean of longest stromal infiltrate diameter and its perpendicular diameter) and 
time from symptom onset to clinic visit (for analyses that included the final visit data). Forwards stepwise selec-
tion was used to create the multivariable model (variables included if p < 0.1 in univariable regression analyses 
and retained if p < 0.05 in likelihood ratio test with full model with all selected variables included).
Results
participants and microbiology. One-hundred and eighty-two participants with FK were initially enrolled 
into the study (FK diagnosed as follows: 143 culture-positive, 30 culture-negative/light microscopy positive, and 
9 microbiologically-negative/IVCM-positive for fungi.) However, 39 patients were excluded from the study due to 
the following reasons: 7 lost to follow-up after the first visit; inability to perform IVCM at the final visit in 32 (due 
to prior corneal perforation in 21, excessive corneal thinning/descemetocele in 3, recent penetrating keratoplasty 
in 7, and 1 patient unable to attend for IVCM imaging). In the final 143 participants included in the study, a total 
of 1647 volume scans were performed (median 11 volume scans per patient, interquartile range 8–13), consisting 
of a total of 65,880 images that were assessed in this study.
Of the patients who reported use of any antimicrobial therapy prior to presentation (n = 126), 23.8% had been 
using natamycin alone (n = 30/126), 5.5% had been using an azole alone (e.g. voriconazole; n = 7/126) and 27.8% 
had been using both natamycin and a topical azole in combination (n = 35/126). After being seen in the cornea 
clinic, the 143 final study participants were commenced on the following intensive (hourly) antifungal eyedrops: 
5% natamycin alone in 93, 5% natamycin and 1% voriconazole in 46, topical 1% itraconazole eyedrops in one, 
initial antibiotic (moxifloxacin) in one until fungal culture results noted at first follow-up visit then natamycin 
started; fortified cefazolin, levofloxacin and polymyxin B ointment in one patient whose ulcer had resolved by the 
time fungal results were available (i.e. culture-negative, equivocal IVCM images at presentation, but found to have 
few fungal filaments on IVCM imaging at a later visits once clinically resolving). An oral antifungal agent was 
given in 103 patients (e.g. itraconazole, ketoconazole, or fluconazole tablet) during the study. In ulcers that were 
Grading Scheme Component Morphological Details
Fungi Linear white hyper-reflective structures, width: 3–6 microns, length up to 400 microns. Often forming a branching pattern (Fig. 1A).
Bullae Dark hypo-reflective lacunae within epithelial cell layer or stromal layer (Fig. 1B).
Scar tissue Stromal tissue of homogenous reflectivity. Usually acellular. Occasionally contains bullae (Fig. 1C).
“Spindles” Very straight linear, hyper-reflective structures with no branching. Often occurring in groups that are parallel to each other (Fig. 1D)
Dendritiform cells
Hyper-reflective cells, with long cellular processes extending outwards in multiple 
directions from the cell body (Fig. 1E). Usually several present in each IVCM image in 
moderate-to-severe fungal keratitis cases.
Normal, quiescent keratocytes Hyper-reflective ovoid nuclei with partially visible cellular processes, connected to cellular processes of adjacent keratocytes in a honeycomb formation (Fig. 2A).
“Activated” keratocytes with visible nuclei Bright hyper-reflective ovoid nuclei with broad cellular processes that are interconnected forming a stellate appearance (Fig. 2B).
“Activated” keratocytes without any visible nuclei As above, broad interconnected stellate appearance of keratocyte network of cellular processes but with no visible ovoid nuclei within the cells (Fig. 2C).
“Granules” Granular appearance of hyper-reflective material (1–2 microns in diameter) within keratocyte cellular processes or within cell nuclei (Fig. 2C).
“Inflammatory” cells
Small, bright hyper-reflective round cells (approx. 10 microns in diameter) often seen 
in large numbers in the affected tissue. Can form a honeycomb distribution within the 
corneal stroma (Fig. 2D).
Table 1. Details of the grading scheme used to classify HRT3 in vivo confocal microscopy images of fungal 
keratitis at each visit.
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found to be clinically worse or not improving at follow-up visits, antifungal treatment was changed as follows: 
topical voriconazole 1% was started in addition to natamycin in 17 patients, itraconazole 1% eye ointment was 
added in addition to natamycin in 18 patients, topical clotrimazole 1% eyedrops (in addition to natamycin alone 
or natamycin and topical voriconazole) was added in three patients.
With maximal medical therapy, by the final visit, 87 ulcers had a “good” outcome (i.e. 31 healed ulcers and 56 
showing improvement by the final visit) and 56 had a “poor” outcome (i.e. 10 perforated, 46 worse or no improve-
ment by the end of the study). Those with a good outcome had slightly shorter symptom duration, smaller ulcer 
size with fewer deep ulcers at enrolment, compared to those with a poor outcome (Table 2). The main causative 
organism in those with good outcome was Fusarium sp. (n = 43/87) and Aspergillus sp. (n = 8/87).
Of the 56 participants in the “poor” outcome group, 36 had an enlarged stromal infiltrate by the final visit, 10 
had no change in the stromal infiltrate from the size at presentation, 10 had developed corneal perforation (of 
whom two had corneal glue), and a total of 16 patients underwent therapeutic penetrating keratoplasty. The com-
monest organisms cultured in poor outcome ulcers were Aspergillus sp. (n = 16/56, including 12 Aspergillus fla-
vus), Fusarium sp. (n = 14/56), and dematiaceous fungi (n = 5: Cylindrocarpon sp. 1, Curvularia sp. 1, Exserohilum 
sp. 2, Lasiodiplodia sp. 1). The 10 perforated ulcers were caused by Fusarium sp. (n = 2), Aspergillus flavus (n = 2), 
dematiaceous fungi (n = 2: Cylindrocarpon sp. and Exserohilum sp.) or were culture-negative but light microscopy 
or IVCM-positive for fungi (n = 4).
Cellular features in baseline and final visit IVCM images associated with good or poor out-
come. The proportion of ulcers with presence of each of the cellular morphologies in baseline and final visit 
IVCM images are shown in Supplementary Table 1. Logistic regression analysis of baseline images alone showed 
that poor outcome was significantly associated with the presence of a stellate appearance of interconnected cells 
without visible nuclei (multivariable OR 2.28, 95% CI: 1.03–5.06, p = 0.043; Table 3), as shown in Fig. 2C.
Multivariable analysis of IVCM images at the final visit showed poor outcome to be associated with the pres-
ence of inflammatory cells in a honeycomb distribution (OR 5.24, 95% CI: 1.44–19.06, p = 0.012) or intact fungal 
hyphae (OR 6.48, 95% CI 2.50–16.78, p < 0.001; Table 3). Good outcome was associated with presence of stromal 
scarring (OR 0.20, 95% CI: 0.08–0.54, p = 0.001; Table 3).
Changes from baseline to final visit associated with good or poor outcome. Multivariable anal-
ysis identified three cellular features that were associated with worsening if they were absent at baseline but were 
present in final visit IVCM images: fungal filaments (OR 3.61, 95% CI: 1.64–7.95, p = 0.001), stromal stellate 
cellular appearance with no visible nuclei (OR 2.09, 95% CI: 1.14–3.82, p = 0.017) and dendritiform cells in the 
stroma (OR 2.88, 95% CI: 1.17–7.11, p = 0.017; Table 3). Change in anterior stromal scar tissue over time, i.e. 
none at baseline but scarring present at final visit, was the only feature associated with good outcome in this anal-
ysis (OR 0.22, 95% CI: 0.10–0.49, p < 0.001, Table 3).
Figure 1. HRT3 in vivo confocal microscopy images at final visit showing: (A) fungal filaments in the corneal 
stroma (arrow shows activated keratocytes with granular intracellular contents), (B) stromal bullae shown by 
arrow, and (C) acellular scar tissue in lower half of image, (D) several “spindles” (indicated by arrow) occurring 
in parallel, adjacent to each other, and (E) dendritiform cells in the anterior stroma.
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Disappearance of fungal filaments in IVCM images over time and outcome. The proportion of 
patients with fungal filaments detected in IVCM images at each visit categorized by clinical outcome is shown 
in Fig. 3. In ulcers that healed or had improved by the final visit, there was an initially steep and then consist-
ent decline in the proportion of patients with visible fungal filaments in IVCM images at each sequential visit. 
However, ulcers that worsened or perforated showed reduction in visible fungal filaments in IVCM images early 
on after presentation, but then an increase in the proportion that had visible fungi in the IVCM images at the 
final visit.
Figure 2. HRT3 in vivo confocal microscopy images of keratocytes in fungal keratitis showing: (A) normal 
keratocyte morphology (bright ovoid nuclei with barely visible cellular processes), (B) stellate interconnected 
cellular processes with bright ovoid nuclei (shown by arrow), (C) stellate interconnected cellular processes 
but no visible nuclei (arrow shows granular intracellular appearance), (D) inflammatory cells in a honeycomb 
distribution.
Poor Outcome (n = 56) Good Outcome (n = 87) p-valuea
Age, median years (IQR) 50 (37–60) 45 (35–55) 0.148
Gender, no. male, (%) 32 (57%) 62 (71%) 0.082
Symptom duration at presentation, median days, (IQR) 7 (4–15) 6 (4–10) 0.022
Days post-enrolment to final visit, median days (IQR) 16 (10–21) 21 (20–23) <0.001
Baseline best-corrected visual acuity, logMAR (IQR) 1.8 (0.8–1.8) 1.0 (0.4–1.8) 0.058
Ulcer infiltrate size, median mm, (IQR)b 5.0 (3.9–5.9) 3.7 (3.1–4.5) <0.001
Posterior 1/3 of cornea affected, n (%) 39 (70%) 43 (49%) 0.017
Table 2. Baseline characteristics of 143 study participants by clinical outcome. aStatistical differences between 
groups assessed using either chi-squared test for proportions or kruskall wallis test for non-parametrically 
distributed continuous variables. bMaximum infiltrate size at presentation, prior to corneal scraping.
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Three of the patients whose ulcers had healed by the final visit (n = 29) still had visible fungi in the IVCM 
images at that time point, as well as evidence of resolving stromal inflammation (i.e. stromal dendritiform 
cells as well as stellate cellular processes with no visible nuclei in 2, but no inflammatory cells in honeycomb or 
non-specific distribution visible in any), and normal keratocyte appearances in the stroma in all 3.
Cellular features associated with corneal perforation. In the univariable regression, no cellular mor-
phologies in baseline or final visit IVCM images were significantly associated with perforation. In terms of change 
over time (i.e. absence of the cellular feature in baseline IVCM images but presence in the final visit images), two 
cellular features were associated with perforation in the multivariable analysis: dendritiform cells in the basal 
epithelial layer appearing in the final visit images (OR 3.31, 95% CI:1.00–10.97, p = 0.05), or a normal keratocyte 
morphology becoming apparent in the final visit images (OR 4.49, 95% CI: 1.14–17.75, p = 0.032).
steroid use. Topical steroid use prior to presentation was not associated with any cellular features in IVCM 
images in the baseline or final visit. Also, topical steroid use did not have any statistically significant effect on 
change in any IVCM cellular morphological features between these two visits and was not significantly associated 
with either good or poor outcome.
Discussion
Here we have described the cellular changes that occur in the cornea during the clinical course of human FK 
as observed with the HRT3 IVCM. We found that several cellular or structural morphologies in IVCM images 
were more likely in ulcers with a poor outcome. The stellate appearance of interconnected cellular processes with 
absence of visible nuclei, if present in the corneal stroma in baseline images, or development of this appearance 
in the final visit images, was an indicator of poor outcome. Although we did not conduct histological studies 
to confirm the cell type associated with this morphological appearance, we compared our images with those 
from previously published IVCM images and found that this appearance has also been reported post-LASIK6, 
and after collagen-crosslinking11. The authors of these studies have postulated that these stellate interconnected 
cells are most likely activated keratocytes, and the absence of visible nuclei may be due to loss of the nuclei 
secondary to a cellular event such as apoptosis6, or due to water retention causing change in refractive indices 
between intra-cellular components during corneal oedema, resulting in increased visibility of cellular processes 
and reduced visibility of the nuclei12. Immunohistochemical studies with TUNEL staining have confirmed that 
keratocyte apoptosis does occur in the human cornea in bacterial, fungal and Acanthamoeba keratitis13,14. The 
stellate inter-connected cellular appearance with absent nuclei that we observed in IVCM images, may be a useful 
warning sign of worsening keratitis - larger studies are required to confirm this finding and histological studies 
are required to elucidate the cell type corresponding to this morphology.
The presence of an inflammatory cell infiltrate forming a honeycomb distribution in IVCM images at the 
final visit was also associated with worsening ulcers in our study. A similar morphological appearance has been 
reported in a mouse model of corneal abrasion injury, where inflammatory cells have been observed to traverse 
along keratocyte processes in a honeycomb pattern using HRT3 IVCM live imaging (in the anaesthetized mouse), 
and the inflammatory cell type confirmed as the neutrophil in immunohistochemical examination of the same 
corneal tissue ex vivo15. Persistence of neutrophils has been associated with worse clinical outcomes and corneal 
Morphological Feature Univariable OR (95% CI) p-value Multivariable OR (95% CI) p-value
(i) Baseline visit only
Stellate cellular processes no nuclei 2.30 (1.04–5.08) 0. 039 2.28 (1.03–5.06) 0.043
Stromal dendritiform cells 2.99 (0.91–9.80) 0.070 2.93 (0.88–9.67) 0.077
(ii) Final visit only
Fungal hyphae 7.25 (3.09–17.02) <0.001 6.48 (2.50–16.78) <0.001
Inflammatory cells (honeycomb) 6.42 (2.07–19.89) <0.001 5.24 (1.44–19.06) 0.012
Scar 0.17 (0.07–0.40) <0.001 0.20 (0.08–0.54) 0.001
Inflammatory cells (non-specific distribution) 2.50 (0.93–6.76) 0.070 — —
(iii) Change from baseline to final visit*
Fungal filaments 4.34 (2.07–9.10) <0.001 3.61 (1.64–7.95) 0.001
Stromal dendritiform cells 2.06 (0.89–4.76) 0.090 2.88 (1.17–7.11) 0.022
Stellate cellular processes with no visible nuclei 1.61 (0.93–2.77) 0.088 2.09 (1.14–3.82) 0.017
Stromal scar 0.27 (0.13–0.54) <0.001 0.22 (0.10–0.49) <0.001
Inflammatory cells in honeycomb distribution 2.14 (1.28–3.89) 0.013 — —
Table 3. Odds ratios (OR) from univariable and multivariable logistic regression models for poor outcome 
(compared to good outcome) and morphological features in IVCM images from (i) baseline only, (ii) final visit 
only, or (iii) features that change from being absent in baseline images to being present in final visit images. 
Models were adjusted for age, gender, baseline ulcer size and time from symptom onset to final visit (for models 
including final visit data). *Conditional logistic regression analysis performed comparing changes within each 
patient from baseline to final visit (i.e. not between patients).
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perforation in BK and FK, most likely due to their ability to release tissue-damaging enzymes (e.g. MMP9) and 
pro-inflammatory cytokines (e.g. IL1B) that perpetuate the host inflammatory response16–18.
Another feature that was associated with worse outcome was the detection of fungal hyphae in final visit 
IVCM images. Persistence of fungi even at later stages of keratitis may be due to inadequate host mechanisms to 
clear the infection; one such mechanism may be through production of molecules that are able to subvert the host 
immune response, e.g. alkaline phosphatase-1 secreted by Aspergillus sp. that is able to destroy host complement 
proteins C3 and C419. Also, poor penetration of natamycin eye drops into the deeper cornea, and poor efficacy of 
this medication against some fungal species such as Aspergillus sp., may contribute to persistence of fungi in the 
deep cornea in late-stage keratitis20,21.
We found that corneal perforation was associated with the appearance of dendritiform cells in the basal epi-
thelial layer in the final visit, or also the appearance of normal keratocyte morphology in final visit image. This 
implies that the fungi in these severe ulcers are able to grow through the cornea successfully with only a superficial 
immune response triggered in the dendritiform cells in the epithelium, and without triggering any response in the 
local keratocytes. Histological studies of corneal tissue excised at the time of corneal transplantation surgery in 
severe FK have shown that regions of the tissue with a high fungal load frequently do not have any inflammatory 
cell infiltration22. Possible reasons for this may be lack of penetration of natamycin into the deeper cornea, or the 
fungal subversion of the host response as outlined above. Corneal perforation may then occur in these cases due 
to fungal proteases damaging corneal collagens, including those in Descemet’s membrane23,24.
The appearance of dendritiform cells in the stroma at the final visit, when not present at the baseline visit, was 
also associated with ulcer worsening. These cells may represent dendritic cells or macrophages that have been 
recruited to the ulcer towards the later stages of disease, or may also represent fibroblasts that are involved in 
wound repair at the site of the ulcer25–27. Further comparative histological studies are required to identify the cell 
type forming this morphological appearance in the IVCM images, in order to understand the role these cells may 
play in the worsening of disease.
One limitation of our study is that although we have identified IVCM cellular appearances, there are poten-
tially multiple cell types that can form these morphologies. For example, cells with a dendritiform appearance in 
IVCM images may be macrophages or dendritic cells that reside within the cornea, but may also be bone-marrow 
derived myeloid cells that have migrated into the inflamed tissue27,28. Correlated images using both IVCM and 
immunohistochemistry within the same tissue sample are required in future studies in order to identify cell 
types and their morphology. Our study has focused on large ulcers and so findings are mainly applicable to 
moderate-to-severe keratitis; further research is required in ulcers at an earlier stages of presentation in order to 
identify whether the same cellular morphologies that we have found are also present in early disease.
Another limitation is that the HRT3 IVCM allows high resolution imaging of the living cornea, but with 
a limited field of view, and so requires multiple images to be taken of the ulcer margins to build up an overall 
picture of cellular changes in the whole ulcer1. As such an experienced operator is required so that the best set of 
images possible are captured. Also, an experienced observer is required to successfully identify the morpholog-
ical features that we have described in our study, and so training would be required. We did not assess inter- or 
intra-grader agreement in this study, as only a single observer was used, however our prior report has shown 
there is variability in inter-grader agreement based upon grader experience2. Hence further studies are required 
to not only validate IVCM image-based prognostic markers, but to also assess the diagnostic accuracy of graders 
in detecting these morphologies. A major limitation of IVCM at present is that the current techniques do not 
allow exact re-imaging of the same cellular location in the cornea at future follow-up visits. In this study we have 
attempted to image as much of the ulcer as possible with multiple volume scans, to try to image as much of the 
ulcer as possible from epithelium to endothelium. Experimental methods are currently underway to combine 
anterior segment OCT techniques with HRT3 IVCM to attempt to be able to co-locate the imaging location 
within the cornea, and so future combined imaging modalities such as this may help to be able to serially assess 
pathological changes in the cornea over time29.
The alternative IVCM system available, Confoscan, provides a motorized lens that allows rapid imaging of 
the entire corneal ulcer quickly for less experienced operators, but will provide lower resolution images, with less 
detail of the keratocyte intracellular changes. However, use of the white light-based Confoscan system (Nidek 
technologies, Japan) in FK in high prevalence settings has in some studies allowed identification of resolution of 
inflammatory cell infiltrates and fungal filaments5, and so further research is required to assess morphological 
parameters in images from this system and whether they may correlate with clinical outcome. Future studies 
Figure 3. Percentage of fungal keratitis patients with fungal filaments detected in HRT3 in vivo confocal 
microscopy imaging (Y-axis) at baseline and at each follow-up visit after enrolment (i.e. visit 1 at day 7 +/− 3 
days; visit 2 at 14 days+/− 3 days or visit 3 at 21 days+/− 3 days, up to 37 days maximum) in the X-axis, for 
each clinical outcome.
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could also consider automation of the assessment of cellular features, such as cell counting to estimate keratocyte 
cell density, or size of dendritiform cells, or to assess the fungal filament load in each images. Automation using 
computational analysis would make such assessments much easier for the inexperienced observer, and also in the 
research setting since the number of total images from all volume scans are often too large to allow for manual cell 
counting or fungal filament tracing (>65,000 images screened in this study alone).
In summary, we have found that several cellular morphologies as detected with HRT3 IVCM may be associ-
ated with worsening versus healing ulcers. Since it can often be difficult to monitor response to treatment with 
clinical examination alone, these specific IVCM features should be further investigated as possible prognostic 
biomarkers.
Data Availability
The datasets generated and/or analysed during the current study are available from the corresponding author on 
reasonable request.
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